CDKL5 and neuroblastoma: The best recovery of defective phenotypes in SH-CDKL5-KO cells was obtained with the P021 dose of 10 μM, while lower concentrations (1 μM) were not effective in recovering the CDKL5-null neuroblastoma phenotype.